A Phase II Study of SKB571 in Patients With Lung Cancer

NCT07230405 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

295

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer (Non-Small Cell)

Interventions

DRUG: SKB571 for injection

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.